Immune Environment Study for Breast Cancer
Role of the Immune Environment in Response to Therapy in Breast Cancer
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Other
This trial is looking for women aged 18 and older with breast cancer. Participants will provide tissue samples to compare different types of breast cancer without any changes to their usual treatment.
You may be able to join if
- I am a woman
- I am 18 years of age or older
- I have been diagnosed with breast cancer
- I am undergoing surgical removal of my cancer
- I am treated at the University of Pennsylvania Health System
You may not be able to join if
- I am male
- I am a child
- I am pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Loading trial locations…